ArticleNeoplasia (New York, N.Y.)2026
Targeting the ELF1/EGFR/ERK positive feedback loop overcomes resistance to androgen receptor inhibition in AR-Vs positive prostate cancer.
Menghan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.